BREWIN DOLPHIN LTD - INNOVATE BIOPHARMACEUTICLS I ownership

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q1 2020$12,580
-9.7%
25,0000.0%0.00%0.0%
Q4 2019$13,928
-47.9%
25,0000.0%0.00%
-66.7%
Q3 2019$26,750
-7.8%
25,0000.0%0.00%0.0%
Q2 2019$29,00025,0000.00%
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,336,248$1,550,0001.95%
Hillview Capital Advisors, LLC 19,610$23,0000.12%
GSA CAPITAL PARTNERS LLP 64,786$75,0000.01%
Virtu Financial LLC 62,822$73,0000.00%
BREWIN DOLPHIN LTD 25,000$29,0000.00%
Paloma Partners Management Co 89,694$104,0000.00%
JANE STREET GROUP, LLC 12,923$15,0000.00%
UBS Group AG 61$00.00%
BARCLAYS PLC 240$00.00%
SIMPLEX TRADING, LLC 337$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders